|
WO2021003416A1
|
|
Monospecific anti-frizzled antibodies and methods of use
|
|
WO2020206005A1
|
|
Modulation of wnt signaling in auditory disorders
|
|
WO2020185960A1
|
|
Modulation of wnt signaling in gastrointestinal disorders
|
|
WO2020167848A1
|
|
Modulation of wnt signalling in ocular disorders
|
|
WO2020132356A1
|
|
Antigen binding formats for receptor complexes
|
|
AU2019301633A1
|
|
Tissue-specific Wnt signal enhancing molecules and uses
|
|
AU2019297522A1
|
|
Multi-specific Wnt surrogate molecules and uses thereof
|
|
US2020308287A1
|
|
Wnt surrogate molecules and uses thereof
|
|
CA3085785A1
|
|
Anti-lrp5/6 antibodies and methods of use
|
|
CA3085782A1
|
|
Wnt surrogate molecules and uses thereof
|
|
US2021087280A1
|
|
Anti-frizzled antibodies and methods of use
|
|
AU2018211985A1
|
|
Tissue-specific Wnt signal enhancing molecules and uses thereof
|
